Literature DB >> 15052240

Effects of therapy with amiodarone on clinical, functional, and cardiac sympathetic innervation in patients with idiopathic dilated cardiomyopathy.

Albert Flotats, Ignasi Carrió.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15052240     DOI： 10.1016/j.nuclcard.2003.12.009

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  21 in total

1.  Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.

Authors:  Myron C Gerson; Laura L Craft; Nancy McGuire; Damodhar P Suresh; William T Abraham; Lynne E Wagoner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Interaction of metaiodobenzylguanidine with cardioactive drugs: an in vitro study.

Authors:  F Huguet; D Fagret; M Caillet; A Piriou; J C Besnard; D Guilloteau
Journal:  Eur J Nucl Med       Date:  1996-05

3.  Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct.

Authors:  D Fagret; J E Wolf; M Comet
Journal:  Eur J Nucl Med       Date:  1989

4.  Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.

Authors:  B M Massie; S G Fisher; M Radford; P C Deedwania; B N Singh; R D Fletcher; S N Singh
Journal:  Circulation       Date:  1996-06-15       Impact factor: 29.690

5.  Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.

Authors:  M Suwa; Y Otake; A Moriguchi; T Ito; Y Hirota; K Kawamura; I Adachi; I Narabayashi
Journal:  Am Heart J       Date:  1997-03       Impact factor: 4.749

6.  Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.

Authors:  G A Somsen; B van Vlies; P A de Milliano; J J Borm; E A van Royen; E Endert; K I Lie
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

7.  Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.

Authors:  Shu Kasama; Takuji Toyama; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

8.  Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart.

Authors:  E M Gilbert; A Sandoval; P Larrabee; D G Renlund; J B O'Connell; M R Bristow
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

9.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

10.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.